CareDx provided earnings guidance for fourth quarter ended December 31, 2023. For the quarter, the company expects revenue to be between $65 million and $66 million, a decrease of approximately 3% compared with $67.2 million in the third quarter of 2023.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
13.65 USD | -3.81% | -8.78% | +13.42% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.42% | 739M | |
-43.90% | 7.73B | |
+11.92% | 3.7B | |
-2.28% | 2.28B | |
-21.56% | 1.99B | |
-23.99% | 1.6B | |
+12.37% | 999M | |
-5.90% | 687M | |
-37.45% | 461M | |
-3.18% | 279M |
- Stock Market
- Equities
- CDNA Stock
- News CareDx, Inc
- CareDx, Inc Provides Earnings Guidance for Fourth Quarter Ended December 31, 2023